Article
Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization.
Journal of neurochemistry - 1 Oct 1997
Koch T, Kroslak T, Mayer P, Raulf E, Höllt V
Abstract excerpt
The rat mu-opioid receptor (rMOR1), expressed in human embryonic kidney 293 (HEK293) cells, shows a desensitization to the inhibitory effect of the mu agonist DAMGO on adenylate cyclase activity within 4 h of DAMGO preincubation. To investigate the role of calcium/calmodulin-dependent protein kinase II (CaM kinase II) on mu-opioid receptor desensitization, we coexpressed rMOR1 and constitutively active CaM kinase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
